Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(14), P. 4243 - 4243
Published: July 20, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
and
polycystic
ovary
syndrome
(PCOS)
are
prevalent
conditions
that
have
been
correlated
with
infertility
through
overlapped
pathophysiological
mechanisms.
MASLD
is
associated
metabolic
considered
among
the
major
causes
of
chronic
disease,
while
PCOS,
which
characterized
by
ovulatory
dysfunction
hyperandrogenism,
one
leading
female
infertility.
The
links
between
PCOS
not
yet
fully
elucidated,
insulin
resistance,
hyperandrogenemia,
obesity,
dyslipidemia
being
key
pathways
contribute
to
lipid
accumulation,
inflammation,
fibrosis,
aggravating
dysfunction.
On
other
hand,
exacerbates
resistance
dysregulation
in
women
creating
a
vicious
cycle
progression.
Understanding
intricate
relationship
crucial
improving
clinical
management,
collaborative
efforts
different
medical
specialties
essential
optimize
fertility
health
outcomes
individuals
PCOS.
In
this
review,
we
summarize
complex
interplay
highlighting
importance
increasing
attention
prevention,
diagnosis,
treatment
both
entities.
Language: Английский
Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis
Histochemistry and Cell Biology,
Journal Year:
2025,
Volume and Issue:
163(1)
Published: Jan. 29, 2025
Language: Английский
Gegen-Qinlian Decoction Alleviates Metabolic Dysfunction-Associated Steatohepatitis by Modulating the Microbiota-Bile Acid Axis in Mice
Xiangbing Shu,
No information about this author
Ying Cao,
No information about this author
Yan Wu
No information about this author
et al.
Published: Jan. 1, 2025
Language: Английский
MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma
Hao Zhang,
No information about this author
Xiangxu Kong,
No information about this author
Haoran Qu
No information about this author
et al.
Oncogene,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 3, 2025
Language: Английский
Gegen-Qinlian decoction alleviates metabolic dysfunction-associated steatohepatitis by modulating the microbiota-bile acid axis in mice
Xiangbing Shu,
No information about this author
Ying Cao,
No information about this author
Yan Wu
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119719 - 119719
Published: April 1, 2025
Language: Английский
Targeting Metabolism: Innovative Therapies for MASLD Unveiled
Weixin Wang,
No information about this author
Xin Gao,
No information about this author
Wei Niu
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4077 - 4077
Published: April 25, 2025
The
recent
introduction
of
the
term
metabolic-dysfunction-associated
steatotic
liver
disease
(MASLD)
has
highlighted
critical
role
metabolism
in
disease’s
pathophysiology.
This
innovative
nomenclature
signifies
a
shift
from
previous
designation
non-alcoholic
fatty
(NAFLD),
emphasizing
condition’s
progressive
nature.
Simultaneously,
MASLD
become
one
most
prevalent
diseases
worldwide,
highlighting
urgent
need
for
research
to
elucidate
its
etiology
and
develop
effective
treatment
strategies.
review
examines
delineates
revised
definition
MASLD,
exploring
epidemiology
pathological
changes
occurring
at
various
stages
disease.
Additionally,
it
identifies
metabolically
relevant
targets
within
provides
summary
latest
targeted
drugs
under
development,
including
those
clinical
some
preclinical
stages.
finishes
with
look
ahead
future
therapy
goal
summarizing
providing
fresh
ideas
insights.
Language: Английский
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB
Yongyuan Zheng,
No information about this author
Yansong Huang,
No information about this author
Weibing Li
No information about this author
et al.
Medical Science Monitor,
Journal Year:
2024,
Volume and Issue:
30
Published: May 15, 2024
Background:MRT4
Homolog,
Ribosome
Maturation
Factor
(MRTO4)
is
often
upregulated
in
cancer
cells.However,
its
impact
hepatocellular
carcinoma
(HCC)
less
well
understood.Herein,
we
explored
the
prognostic
and
energy
metabolism
reprogramming
role
of
MRTO4
HCC.
Material/Methods:Clinical
data
were
obtained
from
The
Cancer
Genome
Atlas
(TCGA),
expression
clinical
samples
was
analyzed.The
association
between
different
variables
overall
survival
(OS)
studied,
as
their
potential
independent
factors,
using
Cox
regression
analysis.We
constructed
a
nomogram
including
pathological
to
provide
predictive
model
for
prognosis.Heatmaps,
Gene
Ontology
(GO),
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
analysis
revealed
relationship
pathways
MRTO4.We
used
classic
molecular
biology
research
methods,
RT-qPCR,
Western
blotting,
CCK8,
TUNEL,
Clone
formation,
Transwell
assay,
ELISA,
immunohistochemistry,
study
promoting
progression
HCC
through
glycolysis
regulation.
Results:Our
showed
that
an
risk
factor
accelerates
cells,
promotes
proliferation
invasion,
suppresses
apoptosis
cells.The
underlying
mechanism
involves
accelerating
by
inhibiting
ALDOB.
Conclusions:Our
novel
which
progression,
suggests
could
be
therapeutic
strategy
Language: Английский
Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(7), P. 7486 - 7504
Published: July 15, 2024
Systemic
sclerosis
(SSc)
is
a
connective
tissue
disorder
characterized
by
microvascular
injury,
extracellular
matrix
deposition,
autoimmunity,
inflammation,
and
fibrosis.
The
clinical
complexity
high
heterogeneity
of
the
disease
make
discovery
potential
therapeutic
targets
difficult.
However,
recent
progress
in
comprehension
its
pathogenesis
encouraging.
Growth
Arrest-Specific
6
(Gas6)
Tyro3,
Axl,
MerTK
(TAM)
receptors
are
involved
multiple
biological
processes,
including
modulation
immune
response,
phagocytosis,
apoptosis,
fibrosis,
cancer
development,
autoimmune
disorders.
In
present
manuscript,
we
review
current
evidence
regarding
SSc
role
Gas6/TAM
system
several
human
diseases,
suggesting
likely
contribution
highlighting
areas
where
further
research
necessary
to
fully
comprehend
TAM
this
condition.
Indeed,
understanding
involvement
SSc,
which
currently
unknown,
could
provide
valuable
insights
for
novel
targets.
Language: Английский
Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model
Biomedical Reports,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Oct. 24, 2024
The
incidence
of
hepatocellular
carcinoma
(HCC)
has
been
rising,
particularly
among
individuals
diagnosed
with
metabolic
dysfunction-associated
steatotic
liver
disease.
In
the
present
study,
prophylactic
effects
rifaximin
(RIF)
on
HCC,
inflammatory
markers
and
cardiovascular
risk
(CVR)
were
investigated
in
an
animal
model.
Adult
Sprague-Dawley
rats
randomly
allocated
into
three
groups
(n=10,
each):
Control
[standard
diet/water
plus
gavage
vehicle
(Veh)],
HCC
[high-fat
choline
deficient
diet
(HFCD)/diethylnitrosamine
(DEN)
drinking
water/Veh
gavage]
RIF
[HFCD/DEN/RIF
(50
mg/kg/day)
groups.
After
euthanasia
at
week
16,
biochemical/inflammatory
histology
assessed.
results
demonstrated
that
animals
had
a
significant
increase
fresh
weight,
weight/body
weight
ratio,
serum
total
cholesterol
(TC),
high-density
lipoprotein-cholesterol,
triglycerides,
hepatic
lipid
accumulation
concentration
triglycerides
TC,
relative
to
controls
(P<0.001,
for
all).
Additionally,
higher
plasminogen
activator
inhibitor,
intercellular
adhesion
molecule-1,
E-selectin
CVR
scores
than
interleukin
(IL)-1β
(P=0.011),
IL-10
(P<0.001),
toll-like
receptor-2
(P=0.012),
lipopolysaccharide-binding
protein
(P=0.018)
metalloproteinase-2
(P=0.003)
levels
animals.
Furthermore,
steatosis,
inflammation
fibrosis,
along
increased
collagen
fiber
deposition
occurred
However,
only
2
rats.
conclusion,
although
most
did
not
develop
positively
affected
involved
steatohepatitis
pathogenesis.
Language: Английский
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency
Cells,
Journal Year:
2024,
Volume and Issue:
13(19), P. 1631 - 1631
Published: Sept. 30, 2024
The
deficiency
of
vitamins,
a
condition
known
as
“hidden
hunger”,
causes
comprehensive
pathological
states.
Research
over
the
years
has
identified
relationship
between
liver
diseases
and
hypovitaminosis
or
defects
in
vitamin
metabolism.
exact
mechanisms
remain
elusive;
however,
crucial
involvement
specific
vitamins
metabolic
functions,
alongside
reclassification
disease
dysfunction-associated
steatotic
(MASLD),
prompted
researchers
to
investigate
potential
cause-effect
dynamics
disease.
Moreover,
scientists
are
increasingly
investigating
how
might
disrupt
organ
crosstalk,
potentially
contributing
Although
concept
dysmetabolic
circuit
linking
adipose
tissue
liver,
leading
disease,
been
discussed,
possible
this
axis
is
relatively
recent
area
study,
with
numerous
critical
aspects
yet
be
fully
understood.
In
review,
we
examine
research
from
2019
July
2024
focusing
on
link
liver-adipose
crosstalk
involved
onset
progression
non-alcoholic
fatty
(NAFLD).
Studies
report
that
can
affect
axis,
mainly
affecting
regulation
systemic
energy
balance
inflammation.
Language: Английский